John­son & John­son do­nates Ebo­la vac­cine amid new out­break; Ji Xing promis­es more than $127M for Mile­stone's nasal spray for rapid heart rate

As John­son & John­son con­tin­ues to roll out its Covid-19 shot, the com­pa­ny is al­so fo­cused on an­oth­er vac­cine.

J&J is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.